Literature DB >> 33032925

Management of Symptomatic Spontaneous Isolated Superior Mesenteric Artery Dissection: A Single Centre Experience with Mid Term Follow Up.

Yadong Shi1, Guoqing Ni2, Boxiang Zhao1, Jianping Gu1, Hao Huang1, Zhaoxuan Lu1, Liang Chen3, Haobo Su4.   

Abstract

OBJECTIVE: This study aimed to report a single centre management experience and mid term outcomes for symptomatic spontaneous isolated superior mesenteric artery dissection (SISMAD).
METHODS: This was a retrospective observational study. Between 1 August 2012, and 30 June 2018, consecutive patients with symptomatic SISMAD were included. Patient demographics, clinical symptoms, comorbidities, risk factors, and dissection characteristics were obtained. The treatment regimens and clinical and follow up outcomes were reviewed and analysed. A chi square test, Fisher's exact test, or one way analysis of variance was used to compare variables between the groups. Binary logistic regression was used to determine predictive factors for failed conservative treatment. The cumulative rate of complete dissection remodelling was calculated using a Kaplan-Meier curve.
RESULTS: Sixty-two patients (mean age, 56.0 ± 9.3 years) were included. Patients at risk of intestinal ischaemia or dissecting aneurysm rupture were considered to be high risk patients (Group 1, n = 16) and received primary endovascular treatment. The remaining patients were considered low risk (Group 2, n = 46) and received primary conservative treatment. Symptom relief was observed in 82.6% of patients in Group 2. Finally, failed conservative treatment was observed in 50% of the low risk patients. Dissection length ≥50 mm was an independent risk factor for failed conservative treatment (p = .019; OR 4.68, 95% CI 1.29-16.98). During a median follow up of 30.5 months (interquartile range, 17.5, 58.3), patients with stents had a higher complete dissection remodelling rate than those without stents.
CONCLUSION: This study found that conservative treatment showed satisfactory symptom resolution for low risk SISMAD patients. Endovascular stenting was associated with a high technical success and dissection remodelling rate. This treatment modality might be reserved for patients with high risk SISMAD or failed conservative treatment. In addition, a dissection length ≥50 mm was a risk factor for failed conservative treatment.
Copyright © 2020 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conservative treatment; Dissection; Endovascular treatment; Superior mesenteric artery

Year:  2020        PMID: 33032925     DOI: 10.1016/j.ejvs.2020.08.010

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  The ratio of superior mesenteric artery diameter to superior mesenteric vein diameter based on non-enhanced computed tomography in the early diagnosis of spontaneous isolated superior mesenteric artery dissection.

Authors:  Yuan-Li Lei; Wen-Xing Song; Yi Lin; Hui-Ping Li; He-Ping Lyu; Jiao-Zhen Chen; Zhang-Ping Li; Jia-Na Yin; Ji-Ke Xue; Shou-Quan Chen
Journal:  World J Emerg Med       Date:  2022

Review 2.  Endovascular therapy versus medical treatment for spontaneous isolated dissection of the superior mesenteric artery.

Authors:  Chenyang Qiu; Ziheng Wu; Yangyan He; Lu Tian; Qianqian Zhu; Tao Shang; Hongkun Zhang; Donglin Li
Journal:  Cochrane Database Syst Rev       Date:  2022-09-08

3.  Clinical characteristics and misdiagnosis of spontaneous isolated superior mesenteric artery dissection.

Authors:  Yuanli Lei; Jinying Liu; Yi Lin; Huiping Li; Wenxing Song; Zhangping Li; Weijia Huang; Shouquan Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-05-25       Impact factor: 2.174

4.  Relationship Between Morphological Remodeling and Angiographic Types of Spontaneous Isolated Superior Mesenteric Artery Dissection After Conservative Management: Determinant Affecting Serial Radiologic Courses.

Authors:  Zihui Yuan; Shi Sheng; Yun You; Defu Li; Qi Wei; Kai Yan; Jian Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.